The founder of Insys Therapeutics Inc. became the highest-ranking pharmaceutical executive to be convicted in a case tied to the U.S. opioid crisis, when he and four colleagues were found guilty of participating in a scheme to bribe doctors to prescribe an addictive painkiller.

U.S. President Donald Trump touted progress in the fight against opioid abuse and promised to hold drugmakers accountable for their part in the crisis, a day after his administration brought its first related criminal charges against a major drug distributor and company executives.

Dozens of medical professionals in Appalachia – a region hard-hit by the U.S. opioid crisis – were charged with writing hundreds of thousands of illegal prescriptions and committing health care fraud, federal prosecutors said.

As America continues to grapple with the opioid crisis, nonprofit advocacy group Public Citizen is calling for the U.S. Food and Drug Administration (FDA) to place a moratorium on the approval of any new opioid medications.

As Scott Gottlieb prepares to step down from his role as commissioner of the U.S. Food and Drug Administration, he sat down with Politico to talk about his two years at the helm of the regulatory agency and what regrets he may be leaving behind.

A judge dismissed lawsuits filed by 37 different municipal governments pertaining to opioid drugmakers being sued in the state of Connecticut.

Here is a look at BioSpace’s top 10 stories of 2018.

Eight medical device makers – including a startup that uses virtual reality to treat chronic pain – topped an innovation contest aimed at addressing the opioid crisis, the U.S. FDA said.

Medical treatment would be more widely available to opioid abusers under a rare bipartisan measure aimed at tackling the U.S. addiction crisis expected to be signed into law by President Trump.

The U.S. Food and Drug Administration warned four online networks that operate 21 websites selling opioids online.